Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Go back to Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 1.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.04 | 52 Week High | $0.92 | |||
| Open | $1.04 | 52 Week Low | $0.32 | |||
| Day High | $1.05 | P/E | N/A | |||
| Day Low | $1.02 | EPS | $-0.18 | |||
| Volume | 14,595 | |||||
